The National Institute on Drug Abuse is offering a grant for clinical research to study the neurobiological mechanisms of Substance Use Disorders. Emphasizing on fundamental brain functions related to substance use, this opportunity supports exploratory projects exceeding R21 budgets, aiming to advance understanding in the field. Closing date: May 07, 2023.
Opportunity ID: 315995
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-282 |
| Funding Opportunity Title: | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 15, 2019 |
| Last Updated Date: | May 15, 2019 |
| Original Closing Date for Applications: | May 07, 2023 |
| Current Closing Date for Applications: | May 07, 2023 |
| Archive Date: | Jun 12, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities State governments Small businesses County governments Special district governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function relevant to substance use. This FOA is particularly designed to support exploratory/developmental projects requiring budgets that would exceed that allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional) |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-282.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 315995 Full Announcement-PAR-19-282 -> PAR-19-282-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00250998 | Sep 10, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260315 | Sep 10, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270557 | Nov 22, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278332 | Nov 14, 2022 | May 07, 2023 | View |
Package 1
Mandatory forms
315995 RR_SF424_2_0-2.0.pdf
315995 PHS398_CoverPageSupplement_4_0-4.0.pdf
315995 RR_OtherProjectInfo_1_4-1.4.pdf
315995 PerformanceSite_2_0-2.0.pdf
315995 RR_KeyPersonExpanded_2_0-2.0.pdf
315995 RR_Budget_1_4-1.4.pdf
315995 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
315995 RR_SubawardBudget30_1_4-1.4.pdf
315995 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
315995 RR_SF424_2_0-2.0.pdf
315995 PHS398_CoverPageSupplement_5_0-5.0.pdf
315995 RR_OtherProjectInfo_1_4-1.4.pdf
315995 PerformanceSite_2_0-2.0.pdf
315995 RR_KeyPersonExpanded_2_0-2.0.pdf
315995 RR_Budget_1_4-1.4.pdf
315995 PHS398_ResearchPlan_4_0-4.0.pdf
315995 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
315995 RR_SubawardBudget30_1_4-1.4.pdf
315995 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
315995 RR_SF424_5_0-5.0.pdf
315995 PHS398_CoverPageSupplement_5_0-5.0.pdf
315995 RR_OtherProjectInfo_1_4-1.4.pdf
315995 PerformanceSite_4_0-4.0.pdf
315995 RR_KeyPersonExpanded_4_0-4.0.pdf
315995 RR_Budget_3_0-3.0.pdf
315995 PHS398_ResearchPlan_4_0-4.0.pdf
315995 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
315995 RR_SubawardBudget30_3_0-3.0.pdf
315995 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 4
Mandatory forms
315995 RR_SF424_5_0-5.0.pdf
315995 PHS398_CoverPageSupplement_5_0-5.0.pdf
315995 RR_OtherProjectInfo_1_4-1.4.pdf
315995 PerformanceSite_4_0-4.0.pdf
315995 RR_KeyPersonExpanded_4_0-4.0.pdf
315995 RR_Budget_3_0-3.0.pdf
315995 PHS398_ResearchPlan_5_0-5.0.pdf
315995 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
315995 RR_SubawardBudget30_3_0-3.0.pdf
315995 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
